Hightide Therapeutics Inc Financial Overview
Hightide Therapeutics Inc's market cap is currently HK$1.33B. The company's EPS TTM is HK$-0.2951542233; its P/E ratio is -3.75; Hightide Therapeutics Inc is scheduled to report earnings on August 25, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
